Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
AQP4-IgG and MOG-IgG related optic neuritis—prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis
AG Filippatou, L Mukharesh, S Saidha… - Frontiers in …, 2020 - frontiersin.org
Background: Optic neuritis (ON) is a cardinal manifestation of multiple sclerosis (MS),
aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated …
aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated …
Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody–associated disease in the United Kingdom
C Satukijchai, R Mariano, S Messina, M Sa… - JAMA network …, 2022 - jamanetwork.com
Importance Longer-term outcomes and risk factors associated with myelin oligodendrocyte
glycoprotein antibody–associated disease (MOGAD) are not well established. Objective To …
glycoprotein antibody–associated disease (MOGAD) are not well established. Objective To …
Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody …
JA Lopez, M Denkova, S Ramanathan… - Clinical & …, 2021 - Wiley Online Library
Autoimmunity plays a significant role in the pathogenesis of demyelination. Multiple
sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD) and myelin …
sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD) and myelin …
[HTML][HTML] Monoclonal antibody therapies beyond complement for NMOSD and MOGAD
V Redenbaugh, EP Flanagan - Neurotherapeutics, 2022 - Elsevier
Abstract Aquaporin-4 (AQP4)-IgG seropositive neuromyelitis optica spectrum disorders
(AQP4-IgG seropositive NMOSD) and myelin oligodendrocyte glycoprotein (MOG)–IgG …
(AQP4-IgG seropositive NMOSD) and myelin oligodendrocyte glycoprotein (MOG)–IgG …
[HTML][HTML] Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
JY Hor, K Fujihara - Frontiers in Neurology, 2023 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …
Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
M Nakamura, R Ogawa, J Fujimori… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: To our knowledge, no nationwide epidemiological study of myelin
oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has been conducted …
oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has been conducted …
Double-negative neuromyelitis optica spectrum disorder
Y Wu, R Geraldes, M Juryńczyk… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Most patients with neuromyelitis optica spectrum disorders (NMOSD) test positive for
aquaporin-4 antibody (AQP4-IgG) or myelin oligodendrocyte glycoprotein antibodies (MOG …
aquaporin-4 antibody (AQP4-IgG) or myelin oligodendrocyte glycoprotein antibodies (MOG …
The long‐term outcome of MOGAD: an observational national cohort study of 61 patients
R Deschamps, J Pique, X Ayrignac… - European Journal of …, 2021 - Wiley Online Library
Background and objective The prognosis in myelin oligodendrocyte glycoprotein (MOG)
antibody‐associated disease (MOGAD) is a matter of debate. Our aim was to assess the …
antibody‐associated disease (MOGAD) is a matter of debate. Our aim was to assess the …
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19
A Francis, J Palace, L Fugger - The Lancet Neurology, 2022 - thelancet.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a rare
condition, with an estimated incidence of up to 3· 4 per million per year (as measured in …
condition, with an estimated incidence of up to 3· 4 per million per year (as measured in …